用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$Meridian Bioscience(VIVO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-10 AccNo: 0001140361-16-051302 Size: 83 KB 网页链接
$Meridian Bioscience(VIVO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001140361-16-050807 Size: 82 KB 网页链接
$Meridian Bioscience(VIVO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-09 AccNo: 0001140361-16-050805 Size: 82 KB 网页链接
$Meridian Bioscience(VIVO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-02-09 AccNo: 0001193125-16-454772 Size: 1 MB 网页链接
$Meridian Bioscience(VIVO)$ 8-K/A [Amend] - Current report Filed: 2016-02-01 AccNo: 0000892251-16-000201 Size: 128 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ht...
$Meridian Bioscience(VIVO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-01-26 AccNo: 0000215457-16-003303 Size: 13 KB 网页链接
$Meridian Bioscience(VIVO)$ ARS [Paper] - Annual Report to Security Holders Film#: 15008558 Filed: 2015-12-21 AccNo: 9999999997-16-016318 Size: 1 KB 网页链接
$Meridian Bioscience(VIVO)$ 内部交易: 2016-01-07,Director,PHILLIPS DAVID ,期权,5214普通股, $15.73
$Meridian Bioscience(VIVO)$ DEF 14A - Other definitive proxy statements Filed: 2015-12-16 AccNo: 0001193125-15-404341 Size: 573 KB 网页链接
$Meridian Bioscience(VIVO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2015-11-30 AccNo: 0001193125-15-390041 Size: 5 MB 网页链接